Obalon Therapeutics Stock Quote OBLN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.05

Bid

2.81

Ask

2.87

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

3.05

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Obalon Announces First Quarter 2021 Financial Results

SAN DIEGO, May 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable...

Obalon Announces Fourth Quarter and Full Year 2020 Financial Results

SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable...

Obalon Announces Third Quarter 2020 Financial Results

SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable...

Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...

Obalon Announces Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable...

Obalon Announces First Quarter 2020 Financial Results and Business Update

SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...

Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment

SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first...

William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director

SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...

Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death...

SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable...

Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives

SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VSTEVast Renewable Ltd	$ 8.97 (86.88%)	2.25M
NUWENewellis Inc	$ 2.325 (70.96%)	1.37M
OMICSingular Genomics Systems Inc	$ 19.96 (48.29%)	40.7k
HRYUHanryu Holdings Inc	$ 0.2679 (25.25%)	2.54M
VKTXViking Therapeutics Inc	$ 90.50 (24.18%)	169.46k
ALBTAvalon GloboCare Corporation	$ 2.20 (-25.17%)	90.04k
EPRXEupraxia Pharmaceuticals Inc	$ 2.40 (-22.58%)	314
FRESFresh2 Group Ltd	$ 1.61 (-21.08%)	1
CEROCERo Therapeutics Holdings Inc	$ 0.0678 (-18.41%)	173.12k
LILMLilium NV	$ 0.08 (-18.03%)	462.48k
ELABElevai Labs Inc	$ 0.02585 (-10.55%)	10M
HRYUHanryu Holdings Inc	$ 0.2679 (25.25%)	2.54M
VSTEVast Renewable Ltd	$ 8.97 (86.88%)	2.25M
SHViShares Short Treasury Bond ETF	$ 110.16 (0.01%)	1.52M
NUWENewellis Inc	$ 2.325 (70.96%)	1.37M